CXCR4 and Miyoshi myopathy: MM has also been further investigated with [68 Ga]PentixaFor [36], demonstrating remarkable diagnostic accuracy for identifying MM manifestations, which was superior relative to [18F]FDG in newly diagnosed subjects (positive rate almost twice for CXCR4 PET) [37].